GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SciBase Holding AB (OSTO:SCIB) » Definitions » Current Ratio

SciBase Holding AB (OSTO:SCIB) Current Ratio : 2.43 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is SciBase Holding AB Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. SciBase Holding AB's current ratio for the quarter that ended in Mar. 2024 was 2.43.

SciBase Holding AB has a current ratio of 2.43. It generally indicates good short-term financial strength.

The historical rank and industry rank for SciBase Holding AB's Current Ratio or its related term are showing as below:

OSTO:SCIB' s Current Ratio Range Over the Past 10 Years
Min: 2.09   Med: 5.08   Max: 18.98
Current: 2.43

During the past 11 years, SciBase Holding AB's highest Current Ratio was 18.98. The lowest was 2.09. And the median was 5.08.

OSTO:SCIB's Current Ratio is ranked worse than
54.85% of 866 companies
in the Medical Devices & Instruments industry
Industry Median: 2.66 vs OSTO:SCIB: 2.43

SciBase Holding AB Current Ratio Historical Data

The historical data trend for SciBase Holding AB's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SciBase Holding AB Current Ratio Chart

SciBase Holding AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.40 4.96 5.62 2.09 3.26

SciBase Holding AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.14 4.14 4.03 3.26 2.43

Competitive Comparison of SciBase Holding AB's Current Ratio

For the Medical Devices subindustry, SciBase Holding AB's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SciBase Holding AB's Current Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SciBase Holding AB's Current Ratio distribution charts can be found below:

* The bar in red indicates where SciBase Holding AB's Current Ratio falls into.



SciBase Holding AB Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

SciBase Holding AB's Current Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Current Ratio (A: Dec. 2023 )=Total Current Assets (A: Dec. 2023 )/Total Current Liabilities (A: Dec. 2023 )
=55.732/17.099
=3.26

SciBase Holding AB's Current Ratio for the quarter that ended in Mar. 2024 is calculated as

Current Ratio (Q: Mar. 2024 )=Total Current Assets (Q: Mar. 2024 )/Total Current Liabilities (Q: Mar. 2024 )
=42.799/17.627
=2.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SciBase Holding AB  (OSTO:SCIB) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


SciBase Holding AB Current Ratio Related Terms

Thank you for viewing the detailed overview of SciBase Holding AB's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


SciBase Holding AB (OSTO:SCIB) Business Description

Traded in Other Exchanges
Address
Landsvagen 39, Sundbyberg, Stockholm, SWE, 172 63
SciBase Holding AB is a medical technology company that develops devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis. SciBase's products include Nevisense and Nevisense Go and to date, the platform addresses the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. It is the only FDA-approved device for the detection of melanoma and the only MDR-approved technology for skin cancer detection in Europe. The company operates in two segments: skin cancer and skin barrier assessment. Its geographical segments are Europe/Rest of the World, the United States/North America, and Asia/Oceania.

SciBase Holding AB (OSTO:SCIB) Headlines

No Headlines